Biodexa Pharmaceuticals (BDRX) Inventory Average (2016 - 2018)
Biodexa Pharmaceuticals (BDRX) posted Inventory Average of $1.1 million for Q4 2018, down 16.9% sequentially from $1.3 million in Q2 2018, and down 10.45% YoY from $1.2 million in Q4 2017.
Biodexa Pharmaceuticals (BDRX) Inventory Average (2016 - 2018) Analysis & Trends
Biodexa Pharmaceuticals has reported Inventory Average for 3 years, with the latest figure at $1.1 million in Q4 2018.
- Quarterly Inventory Average fell 10.45% year-over-year to $1.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $1.1 million (down 10.45% YoY) and the FY2018 annual result came in at $1.0 million, down 11.56% from the prior year.
- Inventory Average fell to $1.1 million in Q4 2018 per BDRX's latest filing, from $1.3 million in the prior quarter.
- Over five years, Inventory Average peaked at $1.3 million in Q2 2018 and troughed at $913407.8 in Q2 2016.
- A 3-year average of $1.1 million and a median of $1.1 million in 2017 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2017 and 2018: Inventory Average climbed 19.46% in 2017, then retreated 10.45% in 2018.
- Over 3 years, Inventory Average stood at $1.1 million in 2016, then advanced by 12.58% to $1.2 million in 2017, then slipped by 10.45% to $1.1 million in 2018.
- According to Business Quant data, Inventory Average over the past three periods registered $1.1 million, $1.3 million, and $1.2 million for Q4 2018, Q2 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.08 Mn |
| Jun 30, 2018 | 1.30 Mn |
| Dec 31, 2017 | 1.21 Mn |
| Jun 30, 2017 | 1.09 Mn |
| Dec 31, 2016 | 1.07 Mn |
| Jun 30, 2016 | 913,407.77 |